Upcoming Global Web Symposia
April 9, 2013
12:00 p.m. - 1:30 p.m. EDT
Biologically active molecules (drugs), with defined molecular properties, can interact with various physiological systems to produce different behaviors. As a scientific discipline, Pharmacology is unique in that it has the tools and approaches to extract from such system-dependent drug behavior the molecular properties of drugs so that predictions of behaviors in all systems (including the therapeutic one) can be made. This process facilitates the interaction of biologist and medicinal chemists to optimize drug activity. This course on experimental design has four parts:
Who Should Attend
Instructor Information: Terry Kenakin Ph.D.
Professor, Department of Pharmacology
University of North Carolina School of Medicine
Chapel Hill NC (formerly of GlaxoSmithKline Research and Development)
Beginning his career as a synthetic chemist, Terry Kenakin received a Ph.D. in Pharmacology at the University of Alberta, Edmonton Canada. After a post-doctoral Fellowship at University College London, U.K., he joined Burrough-Wellcome as an associate Scientist. From there he continued working in drug discovery at Glaxo Inc, GlaxoWellcome. and GlaxoSmithKline Research and Development laboratories at Research Triangle Park, N.C. USA. He currently is a Professor in the Dept. of Pharmacology, University of North Carolina School of Medicine , Chapel Hill N.C.
Dr Kenakin has been involved in drug discovery for over 30 years. Currently he is engaged in studies aimed at the optimal design of drug activity assays systems as well as the discovery and testing of. allosteric molecules for the treatment of diabetes. He is a member of numerous editorial boards as well as Editor-in-Chief of the Journal of Receptors and Signal Transduction and co-Editor in Chief of Current Opinion in Pharmacology. In addition, he has authored numerous articles and has written 9 books on Pharmacology.
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: email@example.com
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersKnowledge Foundation professional services
executive teamtestimonialschi timelinemailing listcareers